Monoclonal Antibody Treatment

Monoclonal antibody treatment for COVID-19 may block the virus that causes COVID-19 from attaching to human cells, making it more difficult for the virus to reproduce and cause harm. Monoclonal antibodies may also neutralize a virus. Eligible to high-risk individuals who have tested positive for COVID within the last 10 days.

Why do patients need it?

Patients who are defined under high-risk criteria should consider Monoclonal Antibody Treatment since it is an extra layer of protection to keep you from getting especially sick from the virus. These high-risk categories include:

Older age
Obesity or being overweight
Pregnancy
Chronic kidney disease
Diabetes
Immunosuppressive disease or immunosuppressive treatment
Cardiovascular disease (including congenital heart disease) or hypertension
Chronic lung diseases (for example, chronic obstructive pulmonary disease, asthma [moderate-to-severe], interstitial lung disease, cystic fibrosis and pulmonary hypertension)
Sickle cell disease
Neurodevelopmental disorders (for example, cerebral palsy) or other conditions that confer medical complexity (for example, genetic or metabolic syndromes and severe congenital anomalies)
Having a medical-related technological dependence (for example, tracheostomy, gastrostomy, or positive pressure ventilation (not related to COVID 19))

Patient Instructions:

Does not require fasting.

$0*

*Must have insurance

How It Works

Your Guide to Prism Health Lab

Decide your services.

Book an appointment.

See a medical specialist.

Receive your results!

Monoclonal Antibody Treatment